Due to the low relative risk of prostate cancer metastasis as indicated by the Gleason score of the positive biopsy cores, the patient was put on an active surveillance program for his prostate cancer, with no direct treatment contingent on stable serum PSA levels. The gene discussed is KLK3; the disease is prostate cancer.